Some directors and executives of Wutong Holding Group (300292.SZ) have completed the reduction of 2.7273 million shares.
Wutong Holdings (300292.SZ) announced that the company's director and president, Zhang Jianguo, and director and vice president cum CFO, Shen...
Announcement from Wutong Holding Group (300292.SZ): The company's director and CEO, Zhang Jianguo, and director, vice president and CFO, Shen Weixin, jointly reduced their holdings of the company's shares by 2.7273 million shares, accounting for 0.20% of the total share capital. This reduction plan has been successfully completed.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
